⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
EBS News
Emergent Biosolutions, Inc.
Vaccine Contract Manufacturing Market to Reach US$11,065.6 Million by 2036, as Immunisation Expansion and Rising Manufacturing Complexity Drive Outsourcing
globenewswire.com
EBS
Blood Plasma Derivatives Market to Reach USD 47.85 Billion by 2032 with a CAGR of 6.77%
globenewswire.com
EBS
GRFS
Blood Plasma Derivatives Market to Reach USD 47.85 Billion by 2032 with a CAGR of 6.77%
globenewswire.com
EBS
GRFS
TAK
EBSCO Information Services Unveils Music Index Archive, Completing Its Trio of Music Research Resources
prnewswire.com
EBS
Emergent BioSolutions Announces $100 Million Paydown of Term Loan Principal, a Significant Step Achieved Toward its Multi-year Transformation
globenewswire.com
EBS
Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026
globenewswire.com
EBS
Emergent BioSolutions and PANTHER Announce Agreement to Support the Continuation of the Africa CDC-led MpOx Study in Africa
globenewswire.com
EBS
Emergent BioSolutions to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
globenewswire.com
EBS
Pearl TV Launching Affordable NEXTGEN TV Converter Box Program to Support Consumer Transition to ATSC 3.0
businesswire.com
CMCSA
SBGI
T
CHTR
NXST
GNTX
EBS
TGNA
Dyna AI to Streamline Point-of-Care Decisions with Integrated Dosing and Medication Safety Information
prnewswire.com
EBS